Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity.
Mizuno S, Muraki Y, Nakatani K, Tanemura A, Kuriyama N, Ohsawa I, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamamoto N, Yamada T, Shiraki K, Takei Y, Nobori T, Okuda M, Isaji S. Mizuno S, et al. Among authors: okuda m. Clin Dev Immunol. 2013;2013:982163. doi: 10.1155/2013/982163. Epub 2013 Sep 26. Clin Dev Immunol. 2013. PMID: 24187567 Free PMC article.
Intravenous Administration of Tacrolimus Stabilizes Control of Blood Concentration Regardless of CYP3A5 Polymorphism in Living Donor Liver Transplantation: Comparison of Intravenous Infusion and Oral Administration in Early Postoperative Period.
Kato H, Usui M, Muraki Y, Okuda M, Nakatani K, Hayasaki A, Ito T, Iizawa Y, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Isaji S. Kato H, et al. Among authors: okuda m. Transplant Proc. 2018 Nov;50(9):2684-2689. doi: 10.1016/j.transproceed.2018.03.049. Epub 2018 Mar 15. Transplant Proc. 2018. PMID: 30401377
Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients.
Mizuno S, Nakatani K, Muraki Y, Tanemura A, Azumi Y, Kuriyama N, Ohsawa I, Kishiwada M, Usui M, Sakurai H, Tabata M, Okuda M, Nobori T, Isaji S. Mizuno S, et al. Among authors: okuda m. Ann Transplant. 2013 Jul 11;18:349-57. doi: 10.12659/AOT.883974. Ann Transplant. 2013. PMID: 23845965
Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype.
Mizuno S, Hamada T, Nakatani K, Kishiwada M, Usui M, Sakurai H, Tabata M, Sakamoto Y, Nishioka J, Muraki Y, Okuda M, Nobori T, Isaji S. Mizuno S, et al. Among authors: okuda m. J Hepatobiliary Pancreat Sci. 2011 Mar;18(2):226-32; discussion 232-4. doi: 10.1007/s00534-010-0335-8. J Hepatobiliary Pancreat Sci. 2011. PMID: 21165655
Immune response following liver transplantation compared to kidney transplantation: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity and cytochrome P450 3A5 genotype assay.
Nobuoka Y, Mizuno S, Nishikawa K, Nakatani K, Muraki Y, Yamada T, Okuda M, Nobori T, Sugimura Y, Isaji S. Nobuoka Y, et al. Among authors: okuda m. Clin Dev Immunol. 2013;2013:936063. doi: 10.1155/2013/936063. Epub 2013 Dec 25. Clin Dev Immunol. 2013. PMID: 24454479 Free PMC article.
Monitoring of peripheral blood cluster of differentiation 4+ adenosine triphosphate activity and CYP3A5 genotype to determine the pharmacokinetics, clinical effects and complications of tacrolimus in patients with autoimmune diseases.
Muraki Y, Mizuno S, Nakatani K, Wakabayashi H, Ishikawa E, Araki T, Taniguchi A, Isaji S, Okuda M. Muraki Y, et al. Among authors: okuda m. Exp Ther Med. 2018 Jan;15(1):532-538. doi: 10.3892/etm.2017.5364. Epub 2017 Oct 24. Exp Ther Med. 2018. PMID: 29375701 Free PMC article.
1,343 results